Search Results

Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance.

• Authors : Huang, Xiaochao; Li, Guimei; Li, Huifang

• Source: Journal of Medicinal Chemistry; 5/23/2024, Vol. 67 Issue 10, p8020-8042, 23p

Record details

Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy.

• Authors : Shi, Jinfeng; Wang, Yehui; Wu, Yihan

• Source: ACS Applied Materials & Interfaces; 2/14/2024, Vol. 16 Issue 6, p7576-7592, 17p

Record details

Core–Shell Nanostructured Drug Delivery Platform Based on Biocompatible Metal–Organic Framework-Ligated Polyethyleneimine for Targeted Hepatocellular Carcinoma Therapy.

• Authors : Fytory, Mostafa; Mansour, Amira; El Rouby, Waleed M. A.

• Source: ACS Omega; 6/13/2023, Vol. 8 Issue 23, p20779-20791, 13p

Record details

A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption.

• Authors : Lai, Yidan; Lu, Nong; Luo, Shuangling

• Source: Journal of Medicinal Chemistry; 10/13/2022, Vol. 65 Issue 19, p13041-13051, 11p

Record details

Gold Nanostars Combined with the Searched Antibody for Targeted Oral Squamous Cell Carcinoma Therapy.

• Authors : Cai, Lingling; Wang, Yanxing; Peng, Xiangrong

• Source: ACS Biomaterials Science & Engineering; 6/13/2022, Vol. 8 Issue 6, p2664-2675, 12p

Record details

Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy.

• Authors : Zhao, Chaochao; Shi, Qin; Li, Hu

• Source: ACS Nano; 5/24/2022, Vol. 16 Issue 5, p8493-8503, 11p

Record details

Reversal of HMGA1-Mediated Immunosuppression Synergizes with Immunogenic Magnetothermodynamic for Improved Hepatocellular Carcinoma Therapy.

• Authors : Yan B; Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education; Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi'an, Shaanxi 710069, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy

• Source: ACS nano [ACS Nano] 2023 May 23; Vol. 17 (10), pp. 9209-9223. Date of Electronic Publication: 2023 May 10.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic

Record details

Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy In Vitro and In Vivo.

• Authors : Xiang, Ya; Huang, Wen; Huang, Cong

• Source: Molecular Pharmaceutics; 9/8/2020, Vol. 17 Issue 9, p3223-3235, 13p

Record details

Multipotent miRNA Sponge-Loaded Magnetic Nanodroplets with Ultrasound/Magnet-Assisted Delivery for Hepatocellular Carcinoma Therapy.

• Authors : Wei Dong; Pengying Wu; Mengfan Qin

• Source: Molecular Pharmaceutics; 8/3/2020, Vol. 17 Issue 8, p2891-2910, 20p

Record details

Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma Therapy.

• Authors : Gu, Mengjie; Toh, Tan Boon; Hooi, Lissa

• Source: ACS Applied Materials & Interfaces; 12/11/2019, Vol. 11 Issue 49, p45427-45441, 15p

Record details